THE DIFFERENTIAL DIAGNOSTIC CAPACITY OF SERUM AMYLOID A PROTEIN BETWEEN INFECTIOUS AND NONINFECTIOUS FEBRILE EPISODES OF NEUTROPENIC PATIENTS WITH ACUTE-LEUKEMIA

被引:12
作者
CASL, MT [1 ]
ROGINA, B [1 ]
GLOJNARICSPASIC, I [1 ]
MINIGO, H [1 ]
PLANINCPERAICA, A [1 ]
JAKSIC, B [1 ]
机构
[1] UNIV ZAGREB, CLIN HOSP MERKUR, DEPT INTERNAL MED, ZAGREB 41000, CROATIA
关键词
SERUM AMYLOID A PROTEIN; ACUTE PHASE PROTEINS; PYREXIA; INFECTIONS; NEUTROPENIA; ACUTE LEUKEMIA; ELISA;
D O I
10.1016/0145-2126(94)90065-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We studied the behavior of four major acute phase proteins (SAA, CRP, ACT and AGP) in pyrexial occurrences of 16 neutropenic patients with acute leukemia. Altogether 37 febrile episodes were recorded; 27 were infectious in origin (microbiologically documented infection and clinically documented infection, MDI/CDI group) and 10 were pyrexias of unknown origin (PUO group). In the MDI/CDI group the mean value for the highest individual SAA concentration was 282 +/- 161 mg/l and in the PUO group 95 +/- 79 mg/l. The corresponding mean values were 4.0 mg/l (range 0.2-5.5 mg/l) in 10 control patients with 1 year remission and 0.8 mg/l (range <0.1-1.2 mg/l) in 30 healthy adults. The peak value of SAA rose above 100 mg/l in 85% of our MDI/CDI pyrexias and in 40% of PUO. More reliable results were obtained when the difference between the value on the day when pyrexia occurred and the previous day was calculated. In that case, the difference was above 75 mg/l in 23 of 27 (85%) MDI/CDI pyrexias and in none of 10 (0%) PUO. In the MDI/CDI group the mean difference was 204 +/- 137 mg/l while it was only 26 +/- 19 mg/l in the PUO group. The statistical significance was very high (p < 0.0001). The CRP monitoring was very inferior to SAA while ACT and AGP monitorings were unsatisfactory.
引用
收藏
页码:665 / 670
页数:6
相关论文
共 23 条
[1]   A RAPID ENZYME-LINKED-IMMUNOSORBENT-ASSAY FOR SERUM AMYLOID-A USING SEQUENCE-SPECIFIC ANTIBODIES [J].
CASL, MT ;
GRUBB, A .
ANNALS OF CLINICAL BIOCHEMISTRY, 1993, 30 :278-286
[2]   CLINICAL RELEVANCE OF SERUM AMYLOID-A PROTEIN MONITORING IN URINARY-TRACT INFECTIONS [J].
CASL, MT ;
SABLJARMATOVINOVIC, M ;
KOVACEVIC, S ;
POCANIC, D ;
PREDENKEREKOVIC, V ;
JAGARINEC, N .
ANNALS OF CLINICAL BIOCHEMISTRY, 1993, 30 :272-277
[3]   PATTERNS OF CYTOKINES, PLASMA ENDOTOXIN, PLASMINOGEN-ACTIVATOR INHIBITOR, AND ACUTE-PHASE PROTEINS DURING THE TREATMENT OF SEVERE SEPSIS IN HUMANS [J].
DOFFERHOFF, ASM ;
BOM, VJJ ;
DEVRIESHOSPERS, HG ;
VANINGEN, J ;
VANDERMEER, J ;
HAZENBERG, BPC ;
MULDER, POM ;
WEITS, J .
CRITICAL CARE MEDICINE, 1992, 20 (02) :185-192
[4]  
DOWTON SB, 1988, SEMIN HEMATOL, V25, P84
[5]  
GRUBB A, 1987, SCAND J CLIN LAB INV, V47, P619
[6]   GUIDELINES FOR THE USE OF ANTIMICROBIAL AGENTS IN NEUTROPENIC PATIENTS WITH UNEXPLAINED FEVER [J].
HUGHES, WT ;
ARMSTRONG, D ;
BODEY, GP ;
FELD, R ;
MANDELL, GL ;
MEYERS, JD ;
PIZZO, PA ;
SCHIMPFF, SC ;
SHENEP, JL ;
WADE, JC ;
YOUNG, LS ;
YOW, MD .
JOURNAL OF INFECTIOUS DISEASES, 1990, 161 (03) :381-396
[7]   ORAL NORFLOXACIN FOR PREVENTION OF GRAM-NEGATIVE BACTERIAL-INFECTIONS IN PATIENTS WITH ACUTE-LEUKEMIA AND GRANULOCYTOPENIA - A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL [J].
KARP, JE ;
MERZ, WG ;
HENDRICKSEN, C ;
LAUGHON, B ;
REDDEN, T ;
BAMBERGER, BJ ;
BARTLETT, JG ;
SARAL, R ;
BURKE, PJ .
ANNALS OF INTERNAL MEDICINE, 1987, 106 (01) :1-7
[8]  
KLASTERSKY J, 1982, REV INFECT DIS, V4, P294
[9]  
Mancini G, 1965, Immunochemistry, V2, P235, DOI 10.1016/0019-2791(65)90004-2
[10]   EARLY HOSPITAL DISCHARGE OF CHILDREN WITH CANCER TREATED FOR FEVER AND NEUTROPENIA - IDENTIFICATION AND MANAGEMENT OF THE LOW-RISK PATIENT [J].
MULLEN, CA ;
BUCHANAN, GR .
JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (12) :1998-2004